There were no statistically significant differences in tumor grade, estrogen receptor (ER) status, progestin receptor (PR) status, or HER2 status between patients who were incarcerated at diagnosis/treatment and patients with no incarceration history. This evidence concerns the gene ERBB2 and neoplasm.